| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.313 | 25.886 | 46.459 | 85.573 | 95.242 | 94.690 | 119.414 | 131.626 | 326.386 | 147.585 |
| Total Income - EUR | 23.528 | 25.895 | 46.767 | 85.582 | 95.254 | 97.858 | 128.478 | 136.709 | 326.962 | 151.295 |
| Total Expenses - EUR | 15.684 | 23.392 | 31.582 | 64.954 | 78.446 | 73.230 | 103.441 | 97.371 | 218.222 | 129.834 |
| Gross Profit/Loss - EUR | 7.844 | 2.504 | 15.185 | 20.627 | 16.808 | 24.628 | 25.037 | 39.337 | 108.740 | 21.461 |
| Net Profit/Loss - EUR | 7.138 | 1.984 | 14.064 | 19.771 | 15.907 | 23.744 | 23.993 | 38.047 | 105.956 | 17.013 |
| Employees | 2 | 2 | 3 | 6 | 7 | 7 | 6 | 4 | 5 | 3 |
Check the financial reports for the company - Dvm Medprevent Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.022 | 14.864 | 11.136 | 70.338 | 123.395 | 123.518 | 114.934 | 121.723 | 152.233 | 147.938 |
| Current Assets | 14.278 | 9.291 | 22.952 | 34.144 | 23.597 | 37.224 | 40.334 | 46.568 | 199.492 | 46.722 |
| Inventories | 3.160 | 3.572 | 5.224 | 5.533 | 572 | 0 | 1.413 | 1.864 | 4.530 | 0 |
| Receivables | 7.661 | 2.599 | 5.245 | 6.762 | 7.431 | 5.168 | 13.093 | 32.358 | 20.595 | 13.238 |
| Cash | 3.457 | 3.120 | 12.484 | 21.849 | 15.594 | 32.056 | 25.828 | 12.347 | 174.368 | 33.484 |
| Shareholders Funds | 11.911 | 13.774 | 14.117 | 20.941 | 36.443 | 59.495 | 82.169 | 39.361 | 138.486 | 49.361 |
| Social Capital | 45 | 45 | 44 | 1.160 | 1.138 | 1.116 | 1.092 | 1.095 | 1.092 | 1.086 |
| Debts | 23.147 | 15.783 | 24.371 | 84.304 | 110.549 | 104.699 | 74.053 | 129.985 | 213.240 | 145.299 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dvm Medprevent Srl